SWOG clinical trial number
S0000B

Prevention of Cataract and Age-Related Macular Degeneration with Vitamin E and Selenium - SELECT Eye Endpoints (SEE)

Closed
Phase
Published
Abbreviated Title
SELECT Eye Endpoints (SEE)
Activated
07/01/2004
Closed
07/31/2015
Participants
Institutions listed in protocol Appendix 19.5

Research committees

Other

Treatment

Selenium Vitamin E

Eligibility Criteria Expand/Collapse

Only SELECT participants may be considered for this study

Publication Information Expand/Collapse

2020

Age-related Macular Degeneration in a Randomized Trial of Selenium and Vitamin E in Men: The SELECT Eye Endpoints (SEE) Study (SWOG S0000B) [Letter to the Editor]

W Christen;A Darke;JM Gaziano;RJ Glynn;P Goodman;LM Minasian;IM Thompson Acta Ophthalmologica Jul 23. doi: 10.1111/aos.14538. Online ahead of print

PMid: PMID32701201

2015

Age-related Cataract in a Randomized Trial of Selenium and Vitamin E in Men: The SELECT Eye Endpoints (SEE) Study

W Christen;R Glynn;JM Gaziano;C Tangen;J Crowley;P Goodman;A Darke;SM Lippman;TE Lad;JD Bearden;GE Goodman;LM Minasian;IM Thompson;CD Blanke;EA Klein JAMA Opthalmology 133(1):17-24

PMid: PMID25232809 | PMC number: PMC4395006

Other Clinical Trials

SWOG Clinical Trial Number
S9808

Long Term Follow-Up Protocol: An Administrative Tool.
Research Committee(s)
Other
Activated
06/15/1998
Open
Phase
SWOG Clinical Trial Number
CTSU/NCICOVID

NCI COVID-19 in Cancer Patients Study (N-CCaPS): A Longitudinal Natural History Study
Research Committee(s)
Other
Early Therapeutics & Rare Cancers
Open
Phase